These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 31650274)
21. Particle engineering at the drug substance, drug product interface: a comprehensive platform approach to enabling continuous drug substance to drug product processing with differentiated material properties. Schenck L; Koynov A; Cote A Drug Dev Ind Pharm; 2019 Apr; 45(4):521-531. PubMed ID: 30609381 [TBL] [Abstract][Full Text] [Related]
22. A mesoporous silica based platform to enable tablet formulations of low dose drugs by direct compression. Sun WJ; Aburub A; Sun CC Int J Pharm; 2018 Mar; 539(1-2):184-189. PubMed ID: 29414125 [TBL] [Abstract][Full Text] [Related]
23. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system. Aguilar-Díaz JE; García-Montoya E; Suñe-Negre JM; Pérez-Lozano P; Miñarro M; Ticó JR Eur J Pharm Biopharm; 2012 Apr; 80(3):638-48. PubMed ID: 22245156 [TBL] [Abstract][Full Text] [Related]
24. Direct compression high functionality excipient using coprocessing technique: a brief review. Mirani AG; Patankar SP; Borole VS; Pawar AS; Kadam VJ Curr Drug Deliv; 2011 Jul; 8(4):426-35. PubMed ID: 21235470 [TBL] [Abstract][Full Text] [Related]
25. Switch of tablet manufacturing from high shear granulation to twin-screw granulation using quality by design approach. Miyazaki Y; Lenhart V; Kleinebudde P Int J Pharm; 2020 Apr; 579():119139. PubMed ID: 32061724 [TBL] [Abstract][Full Text] [Related]
26. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies. Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068 [TBL] [Abstract][Full Text] [Related]
27. Ultrasound-assisted preparation of novel ibuprofen-loaded excipient with improved compression and dissolution properties. Gandhi P; Patil S; Aher S; Paradkar A Drug Dev Ind Pharm; 2016 Oct; 42(10):1553-63. PubMed ID: 26858024 [TBL] [Abstract][Full Text] [Related]
28. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications. Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316 [TBL] [Abstract][Full Text] [Related]
29. Modulating Sticking Propensity of Pharmaceuticals Through Excipient Selection in a Direct Compression Tablet Formulation. Paul S; Sun CC Pharm Res; 2018 Mar; 35(6):113. PubMed ID: 29603027 [TBL] [Abstract][Full Text] [Related]
30. Development of Maltodextrin-Based Immediate-Release Tablets Using an Integrated Twin-Screw Hot-Melt Extrusion and Injection-Molding Continuous Manufacturing Process. Puri V; Brancazio D; Desai PM; Jensen KD; Chun JH; Myerson AS; Trout BL J Pharm Sci; 2017 Nov; 106(11):3328-3336. PubMed ID: 28684263 [TBL] [Abstract][Full Text] [Related]
31. Effects of excipients and curing process on the abuse deterrent properties of directly compressed tablets. Rahman Z; Zidan AS; Korang-Yeboah M; Yang Y; Siddiqui A; Shakleya D; Khan MA; Cruz C; Ashraf M Int J Pharm; 2017 Jan; 517(1-2):303-311. PubMed ID: 27956191 [TBL] [Abstract][Full Text] [Related]
32. Investigation of the potential for direct compaction of a fine ibuprofen powder dry-coated with magnesium stearate. Qu L; Zhou QT; Gengenbach T; Denman JA; Stewart PJ; Hapgood KP; Gamlen M; Morton DA Drug Dev Ind Pharm; 2015 May; 41(5):825-37. PubMed ID: 24738790 [TBL] [Abstract][Full Text] [Related]
33. Nanoamorphous drug products - Design and development. Jog R; Burgess DJ Int J Pharm; 2018 Dec; 553(1-2):238-260. PubMed ID: 30359685 [TBL] [Abstract][Full Text] [Related]
34. Formulation development of medicated chewing gum tablets by direct compression using the SeDeM-Diagram-Expert-System. Zieschang L; Klein M; Jung N; Krämer J; Windbergs M Eur J Pharm Biopharm; 2019 Nov; 144():68-78. PubMed ID: 31493511 [TBL] [Abstract][Full Text] [Related]
35. Manufacturing process transfer to a 30 kg/h continuous direct compression line with real-time composition monitoring. Waněk A; Menarini L; Giatti F; Kubelka T; Consoli F; Funaro C; Stasiak P; Štěpánek F Int J Pharm; 2024 May; 656():124100. PubMed ID: 38609059 [TBL] [Abstract][Full Text] [Related]
36. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns. Jan SU; Khan GM; Hussain I Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of hot-melt extrusion and injection molding for continuous manufacturing of immediate-release tablets. Melocchi A; Loreti G; Del Curto MD; Maroni A; Gazzaniga A; Zema L J Pharm Sci; 2015 Jun; 104(6):1971-1980. PubMed ID: 25761921 [TBL] [Abstract][Full Text] [Related]
38. Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold. Wenzel T; Stillhart C; Kleinebudde P; Szepes A Drug Dev Ind Pharm; 2017 Aug; 43(8):1265-1275. PubMed ID: 28398095 [TBL] [Abstract][Full Text] [Related]
39. Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression. Hirschberg C; Sun CC; Rantanen J J Pharm Biomed Anal; 2016 Sep; 128():462-468. PubMed ID: 27368089 [TBL] [Abstract][Full Text] [Related]
40. Understanding the Factors That Control the Quality of Mini-Tablet Compression: Flow, Particle Size, and Tooling Dimension. Zhao J; Yin D; Rowe J; Badawy S; Nikfar F; Pandey P J Pharm Sci; 2018 Apr; 107(4):1204-1208. PubMed ID: 29233726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]